Project Name: Beatson West of Scotland Cancer Centre Patient Support Videos

Project Summary: 

The Beatson West of Scotland Cancer Centre (BWoSCC or “Beatson) is the largest Specialised Cancer Centre in Scotland.  It provides a “hub and spoke” model for a population which covers 2.9 million, over four Health Boards: NHS Greater Glasgow & Clyde (NHS GGC), NHS Lanarkshire, NHS Ayrshire and Arran and NHS Forth Valley. An internationally renowned teaching centre, the Cancer Centre incorporates the academic units of Medical Oncology, Radiation Oncology, Translational Research and Palliative Care. The centre treats over 10,000 new patients and over 70,000 returning patients annually. Each year, more than100,000 fractions of radiotherapy and 28,000 cycles of chemotherapy are administered within the centre. Traditionally, the clinical teams also deliver medical cancer treatments in 13 local hospitals in collaboration with local specialist cancer teams. 

The Collaborative Working Project (CWP) with the Beaston West of Scotland Cancer Centre at NHS Greater Glasgow and Clyde (NHS GGC) aims to develop 6-7 informative oncology related patient videos to enable the following aims:

  • Manage patient and care giver expectations regarding the practicalities of potential oncology treatments and /or procedures and in turn provide increased patient empowerment;
  • Address service capacity levels by alleviating time pressures on oncology healthcare professionals whereby time is spent repeating similar patient queries on a daily basis;
  • Monitor patient and service impact.
  • Share insights and best practice at a national level. (Clinical Audit and Research meeting Scottish BC Annual meeting 2025- managed by MCN) UK BC Group Meeting.) 

Novartis will have the option to utilise the patient education videos within a patient support programme if needed.

Expected Benefits: 

Anticipated Benefits for Patients

  • Increase in patient knowledge in digestible accessible format through video, that can be repeated individually and/or with patient support network.
  • Increase in patient confidence in managing expectations about the practicalities of potential treatment and/or diagnostics.
  • Ability to increase patient empowerment, alleviating queries and potentially reducing the need to contact HCPs as frequently

Anticipated Benefits for The Organisation

  • Release capacity constraints through reducing the HCP time addressing similar patient queries several times a day.
  • Standardising consistency of patient messages via equitable method of communication.
  • Continuing to deliver optimised patient care and treatment levels through utilising media and IT to address patient needs

Anticipated Benefits for Novartis

  • Opportunity to provide product agnostic patient video education on SACT therapy, of which Novartis has a licensed medicine.
  • Ethical, professional, and transparent relationship between Novartis and the Healthcare Organisations
  • Enhanced reputation, and supporting Novartis’ vision that no patient should have to wait for an extraordinary life, by supporting high quality Collaborative Working with healthcare organisations which addresses the problem of health inequalities

Start Date & Duration: December 2024 for 24 months

FA-11564862 | November 2025